Strangles Vaccine
In Stock
Dechra Strangvac vaccine is indicated for horses at high risk of exposure to the bacterium Streptococcus equi.
INDICATIONS
- High-Risk Environments: Livery yards, equestrian centers, studs, and premises receiving many new horses.
- Frequent Travel: Horses attending shows, clinics, or group rides.
- Young Horses: Weanlings and yearlings are particularly susceptible.
- Poor Biosecurity: Yards with suboptimal management or frequent interaction with outside horses.
- Controlling Outbreaks: To reduce infection severity and shedding, minimizing yard-wide risk.
What is does
- Protects against strangles: Protects against infection from Streptococcus equi, a common cause of strangles in horses.
- Reduces clinical signs: Lowers the severity of symptoms, including high temperature, coughing, and difficulty swallowing.
- Decreases abscesses: Helps reduce the formation of lymph node abscesses.
- Minimizes disease spread: Vaccinated horses shed fewer bacteria, reducing the risk of transmitting the disease to other horses.
- Has DIVA capability: The vaccine is designed to differentiate between vaccinated and infected animals (DIVA) on diagnostic tests.
ADMINISTRATION
- Shake Well: Always shake the vial thoroughly before use.
- Injection Site: Administer intramuscularly (IM), typically in the neck or hindquarters.
- Dose: One 2 ml dose.
Vaccination Schedule:
- Primary Course: Two doses, 4 weeks apart, starting from 5 months of age.
- Booster: Every 6-12 months, especially for high-risk horses where a booster might be needed after 2 months.
- Restarting: If a booster is missed by more than one month, the primary course may need to be repeated.
